as on October 16, 2025 at 1:29 am IST
Day's Low
Day's High
2.42%
Downside
0.37%
Upside
52 Week's Low
52 Week's High
29.20%
Downside
3.90%
Upside
Check Vanda Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$309.0M
EPS (TTM)
-1.8067
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.96%
PE Ratio (TTM)
-27.85
Industry PE ratio
-0.32286624203821657
PEG Ratio
-2.42
EBITDA
-92.9M
Revenue (TTM)
203.5M
Profit Margin
-32.90%
Return On Equity TTM
3282700.00%
Track how Vanda Pharmaceuticals Inc. P/E has moved over time to understand its valuation trends.
Vanda Pharmaceuticals Inc. in the last 5 years
Lowest (-50.41x)
March 31, 2024
Today (-27.85x)
October 15, 2025
Industry (-0.32x)
October 15, 2025
Highest (87.99x)
September 30, 2022
Today’s Price to Earnings Ratio: -27.85x
Compare market cap, revenue, PE, and other key metrics of Vanda Pharmaceuticals Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $309.0M | -52.67% | -27.85 | -32.90% | |
BUY | $60.9B | 226.08% | -505.15 | -12.96% | |
NA | $37.1B | NA | NA | -3.89% | |
BUY | $104.4B | 91.48% | 28.99 | 31.86% | |
BUY | $59.1B | -2.15% | 14.07 | 31.37% |
The Vanda Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Vanda Pharmaceuticals Inc. investment value today
Current value as on today
₹1,16,915
Returns
₹16,915
(+16.91%)
Returns from Vanda Pharmaceuticals Inc. Stock
₹12,083 (+12.08%)
Dollar Returns*
₹4,831 (+4.83%)
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Vanda Pharmaceuticals Inc.. Average target price of $12.67
Get share price movements and forecasts by analysts on Vanda Pharmaceuticals Inc..
What analysts predicted
57.54%UPSIDE
Target Price
$12.67
Current Price
$5.38
Analyzed by
7 Analysts
Target
$12.67
Vanda Pharmaceuticals Inc. target price $12.67, a slight upside of 57.54% compared to current price of $5.38. According to 7 analysts rating.
Search interest for Vanda Pharmaceuticals Inc. Stock has increased by 90% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:90% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 01 October
Thu, 02:34 AM
-Vanda Pharmaceuticals announces a collaborative framework with FDA to resolve disputes regarding HETLIOZ® and tradipitant.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 50.04M → 52.59M (in $), with an average increase of 4.9% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, -29.49M → -27.20M (in $), with an average increase of 8.4% per quarter
Price Rise
In the last 1 month, VNDA stock has moved up by 17.3%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 56.2% return, outperforming this stock by 49.5%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 153.0% return, outperforming this stock by 199.7%
Organisation | Vanda Pharmaceuticals Inc. |
Headquarters | 2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037 |
Industry | Health Technology |
CEO | Dr. Mihael H. Polymeropoulos M.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Mihael H. Polymeropoulos M.D. | Founder, President, CEO & Chairman of The Board |
Mr. Kevin Patrick Moran | Senior VP, CFO & Treasurer |
Mr. Timothy Williams J.D. | Senior VP, General Counsel & Secretary |
Mr. Joakim Wijkstrom | Senior VP & Chief Marketing Officer |
Mr. Gunther Birznieks | Senior Vice President of Business Development |
Mr. Scott L. Howell | Chief People Officer |
Vanda Pharmaceuticals Inc. share price today is $5.38 as on at the close of the market. Vanda Pharmaceuticals Inc. share today touched a day high of $5.4 and a low of $5.25.
Vanda Pharmaceuticals Inc. share touched a 52 week high of $5.59 on and a 52 week low of $3.81 on . Vanda Pharmaceuticals Inc. stock price today i.e. is closed at $5.38,which is 3.76% down from its 52 week high and 41.24% up from its 52 week low.
Vanda Pharmaceuticals Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Vanda Pharmaceuticals Inc. (VNDA) shares with as little as ₹87.985 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.85 in Vanda Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Vanda Pharmaceuticals Inc. share’s latest price of $5.38 as on October 16, 2025 at 1:29 am IST, you will get 1.8587 shares of Vanda Pharmaceuticals Inc.. Learn more about
fractional shares .
Vanda Pharmaceuticals Inc. stock has given -52.67% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?